MP, C

Maintenance
Total dose of 5% of HDMTX dose given in 1 2 equally divided doses over 3 days. §short iv. infusion every 6 hr for first 8 doses (days 1 -2), and then last 4 doses given orally (day 3).
IIstart calcium leucovorin exactly 2 hr after the end of the methotrexate infusion. In contrast, therapeutic CSF methotrexate levels were not achieved during induction and consolidation.
Relapses have occurred for both the previously untreated and treated patients (see Table  9 ). The initial site of relapse has been the bone marrow Table  10 ). 
